INTRODUCTION
============

Isoflavones are plant-derived, biologically active compounds that are commonly used as natural drugs or dietary supplements. Due to their multiple biological activities, isoflavones became the subject of intensive studies as potential phytotherapeutic compounds. An isoflavone, tectorigenin, shows potent hypoglycemic activity, anticancer effects, tyrosinase inhibitory activity, and anaphylaxis inhibitory activity.[@b1-jcp-21-257]--[@b3-jcp-21-257] In addition, our previous study demonstrated that tectorigenin, a metabolite formed by transformation of tectoridin by intestinal microflora, has a cytoprotective effect against hydrogen peroxide (H~2~O~2~)-induced cell damage via antioxidant activity.[@b4-jcp-21-257]

Oxygen consumption in aerobic cells is accompanied by the generation of reactive oxygen species (ROS) such as H~2~O~2~, superoxide anion, and hydroxyl radicals. Oxidative stress results from ROS and an imbalance in favor of oxidants over antioxidants, which may affect lipids, DNA, carbohydrates, and proteins,[@b5-jcp-21-257] and thus contributes to inflammation, aging, cancer, arteriosclerosis, hypertension, and diabetes.[@b6-jcp-21-257]--[@b11-jcp-21-257] Cells have developed a variety of antioxidant defense mechanisms for cytoprotection against ROS. Catalase is located in the peroxisome and converts H~2~O~2~ into molecular oxygen and water.[@b12-jcp-21-257] Catalase plays an important role in protection against oxidative stress-induced cell damage.[@b13-jcp-21-257]--[@b17-jcp-21-257] In addition, catalase regulates cell growth by activating the extracellular signal-regulated kinase (ERK) and consequently stimulates cell growth, which is inhibited by oxidative stress.[@b18-jcp-21-257],[@b19-jcp-21-257] The transcription factor NF-κB is implicated in multiple physiological and pathological processes, and regulates gene expression important for mediating stress responses, including cell proliferation, differentiation, inflammation, apoptosis, and cell survival.[@b20-jcp-21-257],[@b21-jcp-21-257] Overexpression of NF-κB results in increased cell viability by blocking apoptosis.[@b22-jcp-21-257] Although tectorigenin has protective effects against H~2~O~2~-induced oxidative stress,[@b4-jcp-21-257] the underlying mechanism has not been elucidated.

Therefore, the present study investigated the mechanisms by which tectorigenin protects against H~2~O~2~-induced oxidative stress in terms of NF-κB and ERK.

MATERIALS AND METHODS
=====================

1. Reagents
-----------

Tectorigenin ([Fig. 1A](#f1-jcp-21-257){ref-type="fig"}) was provided by Professor Dong Hyun Kim (Kyung Hee University, Seoul, Korea). MTT, 3-amino-1,2,4-triazole (ATZ), and BAY 11-7082 ((E)-3-(4-methylphenylsulfonyl)-2-propenenitrile) were purchased from Sigma-Aldrich (St. Louis, MO, USA). An anti-catalase antibody was purchased from Biodesign International Company (Saco, ME, USA). Anti-ERK2 and anti-phospho-ERK1/2 (Thr 202/Tyr 204) antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). U0126 was purchased from Calbiochem (San Diego, CA, USA). Anti-β-actin, anti-IκB-α, and anti-NF-κB antibodies were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). A primary antibody against TATA-binding protein was purchased from Abcam (Cambridge, MA, USA). The NF-κB-binding site-luciferase construct was a generous gift from Dr. Young Joon Surh (Seoul National University, Seoul, Korea). The other chemicals and reagents were of analytical grade.

2. Cell culture
---------------

Chinese hamster lung fibroblasts (V79-4) from the American Type Culture Collection were maintained at 37°C in an incubator in a humidified atmosphere of 5% CO~2~ and cultured in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal calf serum, streptomycin (100 μg/mL), and penicillin (100 units/mL).

3. Cell viability
-----------------

The cytoprotective effect of tectorigenin against H~2~O~2~-treated cell death was determined by assessing cell viability using the MTT assay.[@b23-jcp-21-257] MTT solution was added to each well and incubated for 4 hours. The formazan crystals in each well were dissolved in dimethylsulfoxide, and absorbance at 540 nm was read on a scanning multi-well spectrophotometer.

4. Catalase activity
--------------------

Cells were seeded in a culture dish at a density of 1.5 × 10^5^ cells/mL. At 16 hours after plating, the cells were treated with 10 μg/mL tectorigenin for 3, 6, 12, and 24 hours. The harvested cells were suspended in 10 mM phosphate buffer (pH 7.5) and then lysed on ice by sonication twice for 15 seconds. The lysates were then supplemented with Triton X-100 (1%) and incubated for 10 minutes on ice. The lysates were centrifuged at 5,000 ×*g* for 30 minutes at 4°C to remove cellular debris. The protein content of the supernatant was determined by the Bradford method, and the supernatants were added to 50 mM phosphate buffer (pH 7.0) containing 100 mM H~2~O~2~. The reaction mixture was incubated for 2 minutes at 37°C, and absorbance at 240 nm was monitored for 5 minutes. The change in absorbance over time was proportional to the degradation of H~2~O~2~.[@b24-jcp-21-257] Catalase activity was expressed as units/mg protein, and one unit of enzyme activity was defined as the amount of enzyme required to degrade 1 μM H~2~O~2~.

5. Western blot analysis
------------------------

Cells were harvested and washed twice with phosphate-buffered saline. The harvested cells were then lysed on ice for 30 minutes in 100 μL of lysis buffer (120 mM NaCl, 40 mM Tris \[pH 8\], and 0.1% NP 40) and centrifuged at 13,000 ×*g* for 15 minutes. Supernatants were collected and the protein concentrations were determined. Aliquots of the lysates (40 μg of protein) were electrophoresed in a 10% SDS-polyacrylamide gel. Proteins in the gels were transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA), which were then incubated with anti-catalase, anti-ERK2, anti-phospho-ERK1/2, anti-IκB-α, and anti-NF-κB primary antibodies. The membranes were further incubated with secondary immunoglobulin G-horseradish peroxidase conjugates (Pierce, Rockland, IL, USA), and protein bands were detected using an enhanced chemiluminescence Western blotting detection kit (Amersham, Little Chalfont, Buckinghamshire, UK) and then exposed to x-ray film.

6. Transient transfection and NF-κB luciferase assay
----------------------------------------------------

Cells were transiently transfected with the plasmid harboring the NF-κB promoter using 1,2-Dioleoyloxy-3-trimethylammonium propane chloride as the transfection reagent, according to the manufacturer's instructions (Roche, Mannheim, Germany). Following transfection overnight, the cells were treated with 10 μg/mL tectorigenin for the indicated durations. The cells were then washed twice with phosphate-buffered saline and lysed with reporter lysis buffer (Promega, Madison, WI, USA). Following vortex mixing and centrifugation at 12,000 ×*g* for 1 minute at 4°C, the supernatant was stored at −70°C for the luciferase assay. After mixing 20 μL of the cell extract with 100 μL of the luciferase assay reagent at room temperature, the mixture was placed in an illuminometer to measure the light produced.

7. Electrophoretic mobility shift assay
---------------------------------------

Cells were harvested and subsequently lysed on ice with 1 mL of lysis buffer (10 mM Tris-HCl \[pH 7.9\], 10 mM NaCl, 3 mM MgCl~2~, and 1% NP-40) for 4 minutes. After centrifugation at 3,000 ×*g* for 10 minutes, the pellets were re-suspended in 50 μL of extraction buffer (20 mM HEPES \[pH 7.9\], 20% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM dithiothreitol \[DTT\], and 1 mM phenylmethane sulfonyl fluoride), incubated on ice for 30 minutes, and centrifuged at 13,000 ×*g* for 5 minutes. The supernatant (nuclear protein) was stored at −70°C after determining the protein concentration. Oligonucleotides containing the NF-κB consequence sequence (5′-AGT TGA GGG GAC TTT CCC AGGC-3′) were annealed, labeled with \[γ-^32^P\] ATP using T4 polynucleotide kinase, and used as probes. The probes were incubated with the nuclear extracts at 4°C for 30 minutes in a final volume of 20 μL containing 12.5% glycerol, 12.5 mM HEPES (pH 7.9), 4 mM Tris-HCl (pH 7.9), 60 mM KCl, 1 mM EDTA, and 1 mM DTT together with 1 mg of poly (dI-dC). Binding products were resolved on a 5% polyacrylamide gel, and the bands were visualized by autoradiography.[@b25-jcp-21-257]

8. Statistical analysis
-----------------------

All measurements were made in triplicate and all values represent means ± SE. The results were subjected to an analysis of the variance using Tukey's test to analyze the differences. *P* \< 0.05 was considered significant.

RESULTS
=======

1. Effect of tectorigenin on cell damage induced by hydrogen peroxide
---------------------------------------------------------------------

The protective effect of tectorigenin against H~2~O~2~-induced cell death was measured using the MTT test. Cells were treated with 10 μg/mL tectorigenin for 1 hour prior to the addition of H~2~O~2~, and cell viability was determined 24 hours later by the MTT assay. Treatment with tectorigenin increased cell viability to 84% compared with 66% for H~2~O~2~-treated cells ([Fig. 1B](#f1-jcp-21-257){ref-type="fig"}), indicating that tectorigenin protected against cell damage induced by H~2~O~2~ treatment.

2. Effect of tectorigenin on catalase
-------------------------------------

To investigate whether the cytoprotective effect of tectorigenin against oxidative stress was associated with the activation of anti-oxidant enzymes, catalase activity was measured in tectorigenin-treated cells. Catalase activity was increased by tectorigenin in a time-dependent manner and reached 28 U/mg protein at 24 hours ([Fig. 2A](#f2-jcp-21-257){ref-type="fig"}). The expression of catalase protein by tectorigenin was determined by Western blot analysis. In the presence of tectorigenin, protein expression of catalase was increased within 24 hours ([Fig. 2B](#f2-jcp-21-257){ref-type="fig"}). To confirm the effect of catalase in tectorigenin-induced cytoprotection against H~2~O~2~-induced damage, cells were pre-treated with 20 mM ATZ, a specific inhibitor of catalase,[@b26-jcp-21-257] for 30 minutes, followed by incubation with tectorigenin for 30 minutes and exposure to 1 mM H~2~O~2~ for 24 hours. ATZ treatment abolished the protective effect of tectorigenin in H~2~O~2~-damaged cells ([Fig. 2C](#f2-jcp-21-257){ref-type="fig"}).

3. Effect of tectorigenin on extracellular signal-regulated kinase and NF-κB
----------------------------------------------------------------------------

The expression and activity of catalase are increased via ERK and the transcription factor NF-κB.[@b27-jcp-21-257] To better understand the mechanism underlying the protective effect of tectorigenin, activation of ERK was examined by Western blotting with a phospho-ERK-specific antibody. Tectorigenin markedly induced phosphorylation of ERK ([Fig. 3A](#f3-jcp-21-257){ref-type="fig"}). However, there was no change in the ERK2 protein level. In addition, to determine the effect of an ERK inhibitor on catalase expression, cells were pre-treated for 30 minutes with U0126 (10 nM), a specific inhibitor of ERK, followed by incubation with tectorigenin for 30 minutes and exposure to 1 mM H~2~O~2~ for 24 hours. U0126 treatment attenuated expression of catalase, which was protected by tectorigenin treatment in H~2~O~2~-damaged cells ([Fig. 3B](#f3-jcp-21-257){ref-type="fig"}). Furthermore, to determine the effect of the ERK inhibitor on tectorigenin-mediated protection against H~2~O~2~-induced damage, cells were pre-treated with the ERK inhibitor for 30 minutes, followed by incubation with tectorigenin for 30 minutes and exposure to 1 mM H~2~O~2~ for 24 hours. U0126 treatment abolished the protective effect of tectorigenin in H~2~O~2~-damaged cells ([Fig. 3C](#f3-jcp-21-257){ref-type="fig"}). These data suggested that the cytoprotective effect of tectorigenin involves activation of the ERK pathway.

We next determined whether tectorigenin activated NF-κB. Tectorigenin treatment enhanced nuclear NF-κB level and decreased IκB-α protein expression in the cytosol ([Fig. 4A](#f4-jcp-21-257){ref-type="fig"}). NF-κB activation in tectorigenin-treated cells was assessed by the electrophoretic mobility shift assay with an oligonucleotide harboring a consensus NF-κB-binding element. Tectorigenin-treated cells exhibited a high level of NF-κB binding ([Fig. 4B](#f4-jcp-21-257){ref-type="fig"}). The transcriptional activity of NF-κB was also assessed using a promoter construct containing the NF-κB-binding DNA consensus site linked to a luciferase reporter gene. Tectorigenin increased the transcriptional activity of NF-κB ([Fig. 4C](#f4-jcp-21-257){ref-type="fig"}). To determine the effect of a NF-κB inhibitor on the protective effect of tectorigenin against H~2~O~2~-induced damage, cells were pre-treated for 30 minutes with BAY 11-7082 (1 μM), a NF-κB-specific inhibitor, followed by incubation with tectorigenin for 30 minutes and exposure to 1 mM H~2~O~2~ for 24 hours. BAY 11-7082 treatment abolished the protective effect of tectorigenin in H~2~O~2~-treated cells ([Fig. 4D](#f4-jcp-21-257){ref-type="fig"}), indicating that NF-κB is also involved in the protective effect of tectorigenin against H~2~O~2~-induced cell damage.

DISCUSSION
==========

Our previous study showed that tectorigenin exerts a cytoprotective effect against H~2~O~2~-induced cell damage.[@b4-jcp-21-257] Catalase effectively improves antioxidant defense mechanisms in cells. In the present study, tectorigenin increased the activity and protein expression of catalase in a time-dependent manner and the protective effect of tectorigenin was abolished by a catalase inhibitor, suggesting that the cytoprotective effect of tectorigenin was modulated by catalase. Antioxidant enzymes may be potential target molecules mediating the anti-apoptotic functions of NF-κB against oxidative stress. Sequence analysis of antioxidant enzymes revealed putative binding sites for NF-κB.[@b28-jcp-21-257] The expression and activity of catalase are regulated through the ERK and NF-κB.[@b27-jcp-21-257] Phospho-ERK phosphorylates cytoplasmic and nuclear targets, and participates in proliferation, differentiation, and movement.[@b29-jcp-21-257] Based on these findings, we studied the activation of ERK, which is an important component of intracellular signaling cascades that mediate survival upon oxidative stress. The level of phospho-ERK was increased in tectorigenin-treated cells, and the effect of tectorigenin on catalase expression and its protective activity in H~2~O~2~-damaged cells were abolished upon treatment with a specific inhibitor of ERK. This suggests that the cytoprotective effect of tectorigenin involves activation of the ERK pathway. In addition, NF-κB was activated in tectorigenin-treated cells. Regulation of NF-κB appears to involve phosphorylation of its subunits (e.g., p65) or dissociation from IκB family members. In our study, NF-κB was activated by tectorigenin, and treatment with a NF-κB inhibitor attenuated the cytoprotective effect of tectorigenin.
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![Protective effect of tectorigenin against H~2~O~2~-induced cell damage. (A) The chemical structure of tectorigenin. (B) The viability of V79-4 cells following H~2~O~2~ treatment was determined by the MTT assay. \*Significantly different from control cells (*P* \< 0.05). \*\*Significantly different from H~2~O~2~-treated cells (*P* \< 0.05).](jcp-21-257f1){#f1-jcp-21-257}

![Effect of tectorigenin on catalase. (A) Catalase activity is expressed as the average number of enzyme units per milligram of protein ± SE. \*Significantly different from control cells (*P* \< 0.05). (B) Cell lysates were electrophoresed and expression of catalase was detected using a specific antibody. (C) After treatment with 3-amino-1,2,4-triazole (ATZ), tectorigenin, and/or H~2~O~2~, cell viability was determined by the MTT assay. \*Significantly different from H~2~O~2~-treated cells (*P* \< 0.05). \*\*Significantly different from tectorigenin plus H~2~O~2~-treated cells (*P* \< 0.05).](jcp-21-257f2){#f2-jcp-21-257}

![Effect of tectorigenin on extracellular signal-regulated kinase (ERK) activity. (A) Cell lysates were electrophoresed and phospho-ERK1/2 and ERK2 were detected using specific antibodies. (B) After treatment with U0126, tectorigenin, and/or H~2~O~2~, catalase expression was detected using a specific antibody and (C) cell viability was determined by the MTT assay. \*Significantly different from H~2~O~2~-treated cells (*P* \< 0.05). \*\*Significantly different from tectorigenin plus H~2~O~2~-treated cells (*P* \< 0.05).](jcp-21-257f3){#f3-jcp-21-257}

![Effect of tectorigenin on NF-κB activity. (A) Cytosolic IκB-α and nuclear NF-κB (p65) from tectorigenin-treated cells were detected using specific antibodies. β-actin and TATA-binding protein (TBP) were used as loading controls for the cytosolic and nuclear fractions, respectively. (B) The DNA-binding activity of NF-κB from tectorigenin-treated cells was detected using an electrophoretic mobility shift assay. (C) The transcriptional activity of NF-κB in tectorigenin-treated cells was assessed using a NF-κB-binding site-luciferase construct. \*Significantly different from control cells (*P* \< 0.05). (D) After treatment with BAY 11-7082, tectorigenin, and/or H~2~O~2~, cell viability was determined by the MTT assay. \*Significantly different from H~2~O~2~-treated cells (*P* \< 0.05). \*\*Significantly different from tectorigenin plus H~2~O~2~-treated cells (*P* \< 0.05).](jcp-21-257f4){#f4-jcp-21-257}
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